| Transmembrane TNF-TNFR2 signaling as a critical immunoregulatory node in pancreatic cancer EM Dickey, A Bianchi, H Amirian, PJ Hosein, D Faustman, R Brambilla, ... Oncoimmunology 13 (1), 2326694, 2024 | | 2024 |
| Su1179 MICROBIAL METABOLITE UROLITHIN A REDUCES INFLAMMATION AND ENHANCES GUT BARRIER FUNCTION IN KRASG12D INHIBITOR MRTX1133-TREATED MOUSE MODELS OF PANCREATIC CANCER V Krishnamoorthy, S Mehra, S Jinka, H Amirian, EW Box, S Singh, ... Gastroenterology (New York, NY 1943) 166 (5), S-686-S-686, 2024 | | 2024 |
| A case of spontaneous abdominal hemoperitoneum secondary to ruptured splenosis A Gunda, MP Martos, EM Dickey, AS Livingstone, C Hester Journal of Surgical Case Reports 2024 (5), rjae284, 2024 | | 2024 |
| Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer MP Martos, H Amirian, EM Dickey, EW Box, NB Merchant, PJ Hosein, ... Hepatobiliary Surgery and Nutrition 13 (2), 325, 2024 | | 2024 |
| CREB-ROCK driven extracellular matrix remodeling exasperates pancreatic cancer progression S Jinka, S Mehra, V Krishnamoorthy, A Bianchi, K Rajkumar, A Adams, ... Cancer Research 84 (6_Supplement), 4277-4277, 2024 | | 2024 |
| Black Race and CA 19-9 Nonproduction is Associated with Limited Pathologic Response to Neoadjuvant Chemotherapy in Patients with Localized Pancreatic Cancer MP Martos, EM Dickey, UR Yanala, K Abdilleh, I Ogobuiro, EW Box, ... ANNALS OF SURGICAL ONCOLOGY 31 (1), S167-S168, 2024 | | 2024 |
| Patient Selection and Outcomes with Hepatic Artery Infusion Chemotherapy (HAIC) in Unresectable Colorectal Liver Metastasis (uCRLM) at a Tertiary Referral Center EM Dickey, KL Koch, H Amirian, F Alessandrino, J Kronenfeld, IDC Silva, ... ANNALS OF SURGICAL ONCOLOGY 31 (1), S204-S204, 2024 | | 2024 |
| Utility of circulating tumor DNA (ctDNA) for detection of minimal residual disease (MRD) after curative-intent therapy in localized pancreatic cancer (PDAC) UR Yanala, M Martos, EM Dickey, A Corona, N Ezenwajiaku, J Pizzolato, ... ANNALS OF SURGICAL ONCOLOGY 31 (1), S23-S24, 2024 | | 2024 |
| Disrupting TNFR2 Signaling Improves Chemotherapy sensitivity in Pancreatic Cancer H Amirian, Bianc-, Anna, I, K Rajkumar, A-am, Andrew, IDC Silva, ... ANNALS OF SURGICAL ONCOLOGY 31 (1), S29-S29, 2024 | | 2024 |
| JNK inhibition reprograms the tumor-immune-microenvironment to overcome chemoresistance in PDAC EW Box III, S Singh, VT Garrido, S Mehra, H Amirian, EM Dickey, ... ANNALS OF SURGICAL ONCOLOGY 31 (1), S61-S62, 2024 | | 2024 |
| Association of race and CA 19-9 nonproduction with limited pathologic response to neoadjuvant chemotherapy in patients with localized pancreatic cancer. MP Martos, EM Dickey, UR Yanala, K Abdilleh, I Ogobuiro, EW Box, ... Journal of Clinical Oncology 42 (3_suppl), 609-609, 2024 | | 2024 |
| Utility of circulating tumor DNA (ctDNA) for the detection of minimal residual disease (MRD) after curative-intent therapy for patients with localized pancreatic adenocarcinoma … UR Yanala, MP Martos, EM Dickey, AM Corona, N Ezenwajiaku, ... Journal of Clinical Oncology 42 (3_suppl), 695-695, 2024 | | 2024 |
